Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BX-004 by BiomX for Resistant Pseudomonas aeruginosa Infections: Likelihood of Approval
BX-004 is under clinical development by BiomX and currently in Phase II for Resistant Pseudomonas aeruginosa Infections. According to GlobalData,...